Li et al. reported the overexpression of SOX2 in the nuclei of non-small-cell lung cancer (NSCLC) cells and suggested this gene as a promising marker in the diagnosis and treatment of NSCLC [52]. Here, SOX2 is linked to non-small cell lung carcinoma.